Ravulizumab Monitoring Panel:-:Pt:Ser/Plas:-:

Preferred Label : Ravulizumab Monitoring Panel:-:Pt:Ser/Plas:-:;

LOINC status : ACTIVE;

LOINC display name : Ravulizumab Monitoring Panel;

LOINC long common name : Ravulizumab Monitoring Panel;

LOINC short name : Ravulizumab pnl SerPl;

Détails

Origin ID

101923-1;

UMLS CUI

C5781635;

Has component
- Ravulizumab [LOINC component]
- Ravulizumab Monitoring Panel [LOINC component]
Has system
- Plasma [LOINC System]
- Serum [LOINC System]
- Serum or Plasma [LOINC System]
Has time aspect
- Point in time (spot) [LOINC time aspect]
Panel of LOINC codes
- Complement alternate pathway AH50 actual/normal:RelACnc:Pt:Ser:Qn:IA [LOINC code]
- Ravulizumab:MCnc:Pt:Ser:Qn: [LOINC code]
Semantic type(s)
- Clinical Attribute [UMLS semantic type]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients